MedPath

Bleoace

Brand Name: Bleoace

Generic Name: Bleomycin (as Sulfate)

Active
Registration Number

DRP-13391-02

Dosage Form

Powder for Solution for Injection (IM/IV/SC)

Issuance Date

January 22, 2024

Expiry Date

February 16, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength15 Units
Packaging5 mL-capacity Type I Tubular Clear Glass Vial with Grey Butyl Rubber Stopper and White Aluminum Seal [Box of 1’s]

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic Agent
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Bleomycin (as Sulfate)Active
Monograph: bleomycin (as sulfate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform